Last edition
News about "ANVIMO "
Zydus Lifesciences Introduces ANVIMO for Kidney and HSCT Transplant Patients
CMV infection remains one of the most serious complications in transplant patients, often leading to graft failure, decreased survival and prolonged hospital stays.
ANVIMO | 06/03/2025 | By Aishwarya | 313
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members